Anti-IL-1 beta antibody [RM1009]

14 product images

• 

  Western blot - Anti-IL-1 beta antibody [RM1009] (ab283818)

  Blocking and diluting buffer and concentration: 5% NFDM/TBST
  

  Expression of IL-1 beta is induced by LPS treatment. 31-kDa precursor IL-1 beta, 28- and 17.5-kDa proteolytically cleaved IL-1 beta are observed.

  The expression pattern and molecular weight observed is consistent with what has been described in the literature (PMID: 8446594, 19559631)

  Exposure time: Lane 1-3: 3 min ; Lane 4-7: 70 seconds

  All lanes: Western blot - Anti-IL-1 beta antibody [RM1009] (ab283818) at 1/1000 dilution

  Lane 1: U-87 MG (Human glioblastoma-astrocytoma epithelial cell) whole cell lysate at 20 µg

  Lane 2: U-937 (Human histiocytic lymphoma monocyte) whole cell lysate at 20 µg

  Lane 3: U-937 treated with 100nM PMA for 2 days, then 1µg/ml LPS for 13h and add 5µg/ml BFA for another 4 h whole cell lysate at 20 µg

  Lane 4: RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate at 20 µg

  Lane 5: RAW 264.7 treated with 100ng/ml LPS for 4h and add 1µg/ml BFA for another 3 h whole cell lysate at 20 µg

  Lane 6: NR8383 (Rat lung macrophage (alveolar)) whole cell lysate at 20 µg

  Lane 7: NR8383 treated with 100ng/ml LPS for 4h and add 1µg/ml BFA for another 3 h whole cell lysate at 20 µg

  Secondary

  All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/100000 dilution

  Predicted band size: 30 kDa

  Observed band size: 17.5 kDa, 28 kDa, 31 kDa

  This data was developed using ab283818, the same antibody clone in a different buffer formulation.
  

  Blocking and diluting buffer and concentration: 5% NFDM/TBST

  Expression of IL-1 beta is induced by LPS treatment. 31-kDa precursor IL-1 beta, 28- and 17.5-kDa proteolytically cleaved IL-1 beta are observed.

  The expression pattern and molecular weight observed is consistent with what has been described in the literature (PMID: 8446594, 19559631)

  Exposure time: Lane 1-3: 3 min ; Lane 4-7: 70 seconds

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IL-1 beta antibody [RM1009] (ab283818)

  Immunohistochemical analysis of paraffin-embedded Mouse colon carcinom tissue labelling IL-1 beta with ab283818 at 1/500 (1.058 ug/ml) followed by a ready to use LeicaDS9800 (Bond™, Polymer Refine Detection). Positive staining on the lamina propria in mouse colon carcinoma. The section was incubated with ab283818 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin.
  

  Secondary antibody only control: Secondary antibody is a ready to use LeicaDS9800 (Bond™, Polymer Refine Detection).

  Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins.

• 

  Immunocytochemistry - Anti-IL-1 beta antibody [RM1009] (ab283818)

  Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized J774A.1 cells labelling IL-1 beta with ab283818 at 1/50 (10.58 ug/ml) dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 (2 ug/ml) dilution (Green). Confocal image showing cytoplasmic staining in J774A.1 cells treated with Lipopolysaccharides (100 ng/ml) for 4h, with the addition of brefeldin A (1 ug/ml) for the last 3 hours. Alexa Fluor® 594 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 (2.5 ug/ml) dilution (Red). The Nuclear counterstain was DAPI (Blue).
  

  Secondary antibody only control: Secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 (2 ug/ml) dilution.

• 

  Flow Cytometry - Anti-IL-1 beta antibody [RM1009] (ab283818)

  Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized U-937 (Human histiocytic lymphoma monocyte) treated with 100nM PMA for 2days then 1μg/ml LPS treated for 13h and add 5μg/ml BFA for another 4h (Red) / U-937 treated with 100nM PMA for 2days (Green) cells labelling IL-1 beta with ab283818 at 1/500 dilution (0.1ug) compared with a Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat Anti-Rabbit IgG (Alexa Fluor® 488, Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed ab150081) at 1/2000 dilution was used as the secondary antibody.

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IL-1 beta antibody [RM1009] (ab283818)

  Immunohistochemical analysis of paraffin-embedded RAW 264.7 cells labelling IL-1 beta with ab283818 at 1/500 (1.058 ug/ml) followed by a ready to use LeicaDS9800 (Bond™, Polymer Refine Detection). Positive staining on RAW 264.7 cells treated with LPS (100ng/ml for 4+3 hours) added BFA (1μg/ml for 3 hours) (Image A) and no staining on control RAW 264.7 (Image B). The section was incubated with ab283818 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin.
  

  Secondary antibody only control: Secondary antibody is a ready to use LeicaDS9800 (Bond™, Polymer Refine Detection).

  Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins

• 

  Immunocytochemistry - Anti-IL-1 beta antibody [RM1009] (ab283818)

  Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized RAW 264.7 cells labelling IL-1 beta with ab283818 at 1/50 (10.58 ug/ml) dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 (2 ug/ml) dilution (Green). Confocal image showing cytoplasmic and nuclear staining in RAW 264.7 cells transfected with Lipopolysaccharides (100 ng/ml) for 4h, with the addition of brefeldin A (1 ug/ml) for the last 3 hours. (PMID:18490713, PMID:18939951). Alexa Fluor® 594 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 (2.5ug/ml) dilution (Red). The Nuclear counterstain was DAPI (Blue).
  

  Secondary antibody only control: Secondary antibody is Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 (2 ug/ml) dilution.

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IL-1 beta antibody [RM1009] (ab283818)

  Immunohistochemical analysis of paraffin-embedded Mouse lung tissue labelling IL-1 beta with ab283818 at 1/500 (1.058 ug/ml) followed by a ready to use LeicaDS9800 (Bond™, Polymer Refine Detection). Positive staining on mouse lung treated with LPS (1ug/ml for 16 hours) and BFA (1ug/ml for 16h hours) (Image A) and no staining on control mouse lung was observed (Image B). The section was incubated with ab283818 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin.
  

  Secondary antibody only control: Secondary antibody is a ready to use LeicaDS9800 (Bond™, Polymer Refine Detection).

  Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IL-1 beta antibody [RM1009] (ab283818)

  Immunohistochemical analysis of paraffin-embedded Mouse colon tissue labelling IL-1 beta with ab283818 at 1/500 (1.058 ug/ml) followed by a ready to use LeicaDS9800 (Bond™, Polymer Refine Detection). The section was incubated with ab283818 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin.
  

  Negative control: no staining on mouse colon.

  Secondary antibody only control: Secondary antibody is a ready to use LeicaDS9800 (Bond™, Polymer Refine Detection).

  Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins.

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IL-1 beta antibody [RM1009] (ab283818)

  Immunohistochemical analysis of paraffin-embedded Mouse spleen tissue labelling IL-1 beta with ab283818 at 1/500 (1.058 ug/ml) followed by a ready to use LeicaDS9800 (Bond™, Polymer Refine Detection). The section was incubated with ab283818 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument Counterstained with Hematoxylin.
  

  Negative control: no staining on mouse spleen.

  Secondary antibody only control: Secondary antibody is a ready to use LeicaDS9800 (Bond™, Polymer Refine Detection).

  Heat mediated antigen retrieval with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins.

• 

  Immunoprecipitation - Anti-IL-1 beta antibody [RM1009] (ab283818)

  This data was developed using ab283818, the same antibody clone in a different buffer formulation.IL-1 beta was immunoprecipitated from 0.35 mg RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) treated with 100ng/ml LPS for 4h and add 1ug/ml BFA for another 3 h whole cell lysate 10ug with ab283818 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab283818 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(VeriBlot for IP Detection Reagent (HRP) ab131366) was used at 1/5000 dilution.

  Lane 1: RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) treated with 100ng/ml LPS for 4h and add 1ug/ml BFA for another 3 h whole cell lysate 10ug

  Lane 2: ab283818 IP in RAW 264.7 treated with 100ng/ml LPS for 4h and add 1ug/ml BFA for another 3 h whole cell lysate

  Lane 3:Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) instead of ab283818 in RAW 264.7 treated with 100ng/ml LPS for 4h and add 1ug/ml BFA for another 3 h whole cell lysate

  Blocking and dilution buffer and concentration: 5% NFDM/TBST.

  Exposure time:

  All lanes: Immunoprecipitation - Anti-IL-1 beta antibody [RM1009] (ab283818)

  Predicted band size: 30 kDa

• 

  Immunoprecipitation - Anti-IL-1 beta antibody [RM1009] (ab283818)

  This data was developed using ab283818, the same antibody clone in a different buffer formulation.IL-1 beta was immunoprecipitated from 0.35 mg U-937 (Human histiocytic lymphoma monocyte) treated with 100nM PMA for 2 days, then 1�g/ml LPS for 13h and add 5�g/ml BFA for another 4 h, whole cell lysate 10ug with ab283818 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab283818 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(VeriBlot for IP Detection Reagent (HRP) ab131366) was used at 1/5000 dilution.

  Lane 1: U-937 (Human histiocytic lymphoma monocyte) treated with 100nM PMA for 2 days, then 1�g/ml LPS for 13h and add 5�g/ml BFA for another 4 h, whole cell lysate 10ug

  Lane 2: ab283818 IP in U-937 treated with 100nM PMA for 2 days, then 1�g/ml LPS for 13h and add 5�g/ml BFA for another 4 h, whole cell lysate

  Lane 3:Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) instead of ab283818 in U-937 treated with 100nM PMA for 2 days, then 1�g/ml LPS for 13h and add 5�g/ml BFA for another 4 h, whole cell lysate

  Blocking and dilution buffer and concentration: 5% NFDM/TBST.

  Exposure time:

  All lanes: Immunoprecipitation - Anti-IL-1 beta antibody [RM1009] (ab283818)

  Predicted band size: 30 kDa

  Observed band size: 17.5 kDa, 28 kDa, 31 kDa

• 

  Flow Cytometry (Intracellular) - Anti-IL-1 beta antibody [RM1009] (ab283818)

  Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized J774A.1 (Mouse reticulum cell sarcoma monocyte macrophage) treated with 100ng/ml LPS treated for 4h and add 1μg/ml BFA for another 3h (Red) / Untreated control (Green) cells labelling IL-1 beta with ab283818 at 1/500 dilution (0.1ug) compared with a Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat Anti-Rabbit IgG (Alexa Fluor® 488, Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed ab150081) at 1/2000 dilution was used as the secondary antibody.

• 

  Western blot - Anti-IL-1 beta antibody [RM1009] (ab283818)

  Western blot: Anti-IL1B antibody [RM1009] (ab283818) staining at 1/1000 dilution, shown in green; Mouse anti-Alpha Tubulin [DM1A] (Anti-alpha Tubulin antibody [DM1A] - Loading Control ab7291) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab283818 was shown to bind specifically to IL1B. A band was observed at 34 kDa in wild-type THP-1 cell lysates with no signal observed at this size in IL1B knockout cell line. To generate this image, wild-type and IL1B knockout THP-1 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.

  All lanes: Western blot - Anti-IL-1 beta antibody [RM1009] (ab283818) at 1/1000 dilution

  Lane 1: Wild-type THP-1 Vehicle control: TPA (80 nM overnight) then LPS (0 ng/mL, 6 h) cell lysate at 20 µg

  Lane 2: Wild-type THP-1 TPA (80 nM overnight) then LPS (100 ng/mL, 6 h) cell lysate at 20 µg

  Lane 3: IL-1b knockout THP-1 Vehicle control: TPA (80 nM overnight) then LPS (0 ng/mL, 6 h) cell lysate at 20 µg

  Lane 4: IL-1b knockout THP-1 TPA (80 nM overnight) then LPS (100 ng/mL, 6 h) cell lysate at 20 µg

• 

  Western blot - Anti-IL-1 beta antibody [RM1009] (ab283818)

  Expression of IL-1 beta is induced by LPS treatment. 31-kDa precursor IL-1 beta, 28- and 17.5-kDa proteolytically cleaved IL-1 beta are observed. The expresssion pattern and molecular weight observed is consistent with what has been described in the literature (PMID: 8446594, 19559631).

  Compared with Anti-IL-1 beta antibody [EPR23851-127] ab254360, ab283818 has higher affinity. For better using Anti-IL-1 beta antibody [EPR23851-127] ab254360, we recommend loading higher amount of human/rat lysate or using lower antibody dilution.

  Lanes 1 - 6: Western blot - Anti-IL-1 beta antibody [EPR23851-127] (Anti-IL-1 beta antibody [EPR23851-127] ab254360) at 1/1000 dilution

  Lanes 10, 11, 12, 7, 8 and 9: Western blot - Anti-IL-1 beta antibody [RM1009] (ab283818)

  Lanes 1 and 7: Untreated THP-1 (human monocytic leukemia monocyte) whole cell lysate at 20 µg

  Lanes 2 and 8: THP-1 treated with 100ng/ml lipopolysaccharide (LPS) for 3h whole cell lysate at 20 µg

  Lanes 3 and 9: Untreated RAW 264.7 (mouse abelson murine leukemia virus-induced tumor macrophage) whole cell lysate at 20 µg

  Lanes 10 and 4: RAW 264.7 treated with 100 ng/ml LPS and 300 ng/ml Brefeldin A (Brefeldin A Solution (1,000X) ab193369) for 4 hours, whole cell lysate at 20 µg

  Lanes 11 and 5: Untreated NR8383 (rat lung macrophage (alveolar)) whole cell lysate at 20 µg

  Lanes 12 and 6: NR8383 treated with 100 ng/ml LPS for 7 hours and 1 µg/ml Brefeldin A (Brefeldin A Solution (1,000X) ab193369) for the last 3 hours, whole cell lysate at 20 µg

  Observed band size: 17.5,28,31 kDa

  Exposure time: 102s